Phospho-NFAT5 (Ser155) Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to Phospho-NFAT5 (Ser155) Antibody

Phospho-NFAT5 (Ser155) Antibody is a specialized immunological reagent targeting the phosphorylated serine residue at position 155 of nuclear factor of activated T cells 5 (NFAT5), a transcription factor critical for cellular responses to osmotic stress and inflammation. This antibody is widely used to study NFAT5 activation dynamics, particularly its nuclear-cytoplasmic shuttling under varying tonicity conditions .

Role in NFAT5 Regulation

  • Nuclear Export Mechanism: Phosphorylation at Ser155 primes NFAT5 for nuclear export under hypotonic conditions. Casein kinase 1 (CK1) phosphorylates Ser155, enabling subsequent phosphorylation at Ser158, which triggers NFAT5 relocation to the cytoplasm .

  • Interaction with Export Machinery: Ser155 phosphorylation facilitates interactions with nuclear export proteins (e.g., XPO1/CRM1), overriding nuclear localization signals under low-osmolarity conditions .

  • Functional Impact: Mutagenesis studies (e.g., Ser155-to-alanine substitutions) demonstrate that blocking phosphorylation at this site retains NFAT5 in the nucleus, even during hypotonic stress .

Experimental Validation

  • Western Blot Applications: The antibody detects endogenous NFAT5 phosphorylation in osmotic stress models, validating its utility in studying regulatory pathways .

  • Cell Localization Studies: Immunostaining with this antibody reveals NFAT5 redistribution during tonicity changes, supporting its role in osmosensing .

Applications in Scientific Research

Phospho-NFAT5 (Ser155) Antibody is instrumental in:

  1. Mechanistic Studies: Elucidating how osmotic stress regulates NFAT5 activity in immune cells, synovial fibroblasts, and epithelial tissues .

  2. Disease Models: Investigating NFAT5 dysregulation in rheumatoid arthritis, skin disorders, and cancer .

  3. Kinase Pathway Analysis: Mapping CK1-dependent signaling cascades that modulate NFAT5 function .

Key Findings and Implications

  • Hypotonic Stress Response: Ser155 phosphorylation is essential for NFAT5’s cytoplasmic retention, preventing excessive transcriptional activity under low-osmolarity conditions .

  • Therapeutic Targets: Inhibiting CK1 or disrupting Ser155 phosphorylation could modulate NFAT5-driven pathologies, such as chronic inflammation .

Table 1: NFAT5 Phosphorylation and Cellular Outcomes

ConditionPhospho-NFAT5 (Ser155) StatusCellular Outcome
Hypertonic StressUnphosphorylatedNuclear retention, transcriptional activation
Hypotonic StressPhosphorylatedCytoplasmic export, reduced DNA binding
CK1 InhibitionReduced phosphorylationPersistent nuclear localization

Product Specs

Form
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
Typically, we can ship your order within 1-3 business days of receipt. Delivery times may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery time estimates.
Synonyms
Glutamine rich protein H65 antibody; KIAA0827 antibody; NF AT5 antibody; NF-AT5 antibody; NFAT 5 antibody; NFAT L1 antibody; NFAT like protein 1 antibody; NFAT5 antibody; NFAT5_HUMAN antibody; NFATL 1 antibody; NFATL1 antibody; NFATZ antibody; Nuclear factor of activated T cells 5 antibody; Nuclear factor of activated T cells 5 tonicity responsive antibody; Nuclear factor of activated T cells antibody; Nuclear factor of activated T-cells 5 antibody; OREBP antibody; Osmotic response element binding protein antibody; T cell transcription factor NFAT 5 antibody; T cell transcription factor NFAT5 antibody; T-cell transcription factor NFAT5 antibody; TonE binding protein antibody; TonE-binding protein antibody; TonEBP antibody; Tonicity responsive enhancer binding protein antibody; Tonicity-responsive enhancer-binding protein antibody
Target Names
Uniprot No.

Target Background

Function
NFAT5 (Nuclear Factor of Activated T-cells 5) is a transcription factor that plays a crucial role in the regulation of various cellular processes, including the transcriptional response to hypertonicity, osmoprotection, and inflammation. It mediates the transcriptional regulation of genes involved in these pathways. NFAT5 positively regulates the transcription of LCN2 and S100A4 genes, with optimal transactivation requiring the presence of DDX5/DDX17. It binds to the DNA consensus sequence 5'-[ACT][AG]TGGAAA[CAT]A[TA][ATC][CA][ATG][GT][GAC][CG][CT]-3'.
Gene References Into Functions
  1. Research indicates that elevated NFAT5 expression correlates with a favorable prognosis in patients with hepatocellular carcinoma (HCC), suggesting a potential tumor-suppressing role for NFAT5. Studies have shown that NFAT5 promotes apoptosis and inhibits cell growth in vitro. Furthermore, it has been observed that Hepatitis B Virus (HBV) inhibits NFAT5 expression by inducing hypermethylation of the AP1-binding site in the NFAT5 promoter. PMID: 29052520
  2. The NFAT5 pathway has been implicated in the regulation of biomechanical stretch-induced proliferation, inflammation, and migration in human arterial smooth muscle cells (HUASMCs). Stretch promotes NFAT5 expression in HUASMCs, which is regulated through the activation of c-Jun N-terminal kinase under these conditions. PMID: 28840417
  3. TonEBP (Tonicity-Responsive Enhancer Binding Protein) suppresses the M2 phenotype in macrophages by downregulating IL-10 production. PMID: 27160066
  4. In addition to identifying proteins already known to interact with NFAT5, numerous novel proteins have been discovered. These proteins suggest new insights into the regulation, interaction, and function of NFAT5. PMID: 27764768
  5. Studies indicate that, in addition to calcium signaling and the activation of inflammatory enzymes, autocrine/paracrine purinergic signaling contributes to the stimulatory effect of hyperosmotic stress on NFAT5 gene expression in retinal pigment epithelial cells. PMID: 28356704
  6. NFAT5-mediated expression of CACNA1C (Calcium Voltage-Gated Channel Subunit Alpha1 C) is evolutionarily conserved and plays a critical role in cardiac electrophysiological development and maturation. PMID: 27368804
  7. Research suggests that protease 2A of Coxsackievirus 3 (CVB3) exhibits substrate specificity, including human/mouse NFAT5 in cardiomyocytes. NFAT5 inhibits CVB3 replication through a mechanism involving iNOS (inducible Nitric Oxide Synthase). However, the anti-CVB3 activity of NFAT5 is impaired during infection due to protease 2A-mediated cleavage of NFAT5. PMID: 29220410
  8. TonEBP expression has been observed to correlate with canonical osmoregulatory targets, including TauT/SLC6A6, SMIT/SLC5A3, and AR/AKR1B1, supporting in vitro findings that the inflammatory milieu during intervertebral disc degeneration (IDD) does not interfere with TonEBP osmoregulation. Notably, TonEBP participates in the proinflammatory response to TNF-alpha. PMID: 28842479
  9. Research has provided evidence that NFAT5 expression in macrophages enhances chronic arthritis by conferring apoptotic resistance to activated macrophages. PMID: 28192374
  10. Genetic variation in NFAT5 expression and function within the central nervous system may influence the regulation of systemic water balance. PMID: 28360221
  11. The hyperosmotic induction of AR (Aldose Reductase) gene expression has been shown to be partially mediated by NFAT5, relying on the activation of metalloproteinases, autocrine/paracrine TGF-beta signaling, activation of p38 MAPK, ERK1/2, and PI3K signal transduction pathways, and the transcriptional activity of NFAT5. PMID: 27628063
  12. miR-20b acts as a tumor suppressor in the development of thymoma and thymoma-associated myasthenia gravis. The tumor suppressive function of miR-20b in thymoma is attributed to its inhibition of NFAT signaling by repressing NFAT5 and CAMTA1 expression. PMID: 27833920
  13. The hyperosmotic, but not the hypoxic, induction of PlGF (Placental Growth Factor) gene expression was partially mediated by NFAT5. PMID: 27230578
  14. Proteins associated with and binding the NH2-terminal region of NFAT5 have been identified. NUP160 and NUP205 contribute to the regulation of NFAT5 transcriptional activity. PMID: 26757802
  15. Data demonstrates the involvement of TonEBP in the mechanisms responsible for osmoadaptation to hyperosmolar stress in retinal pigment epithelial cells. PMID: 26912969
  16. In peritoneal dialysis, the cells of the peritoneal cavity are repeatedly exposed to fluctuations in osmotic concentrations. This review summarizes current information about NFAT5 in uremic patients and patients undergoing peritoneal dialysis. PMID: 26495302
  17. Research suggests that the NFAT5 gene, which is upregulated a few hours after cocaine exposure, may be involved in the genetic predisposition to cocaine dependence. PMID: 26506053
  18. NFAT5 pathway activation may play a significant role in the pathogenesis of inflammatory breast cancer. PMID: 25928084
  19. Real-time PCR and Western blot analysis confirmed the up-regulation of NFAT5 mRNA and nuclear NFAT5 content in human preeclamptic placentas. PMID: 25995271
  20. These findings indicate that NFAT5 plays critical roles in the proliferation and migration of human lung adenocarcinoma cells through regulating AQP5 (Aquaporin 5) expression, suggesting a potential new therapeutic target for lung adenocarcinoma therapy. PMID: 26299924
  21. The hyperosmotic induction of AQP5 and VEGF (Vascular Endothelial Growth Factor) in retinal pigment epithelial cells was partially dependent on NFAT5 activation. PMID: 25878490
  22. Upregulation of NFAT5 in peritoneal dialysis patients is associated with NF-kappaB induction, potentially leading to macrophage recruitment. PMID: 25834072
  23. NFAT5 participates in the regulation of intestinal homeostasis by suppressing the mTORC1/Notch signaling pathway. PMID: 25057011
  24. PKC-alpha contributes to high NaCl-dependent activation of NFAT5 through ERK1/2. PMID: 25391900
  25. Data suggests that nuclear factor of activated T cells 5 (NFAT5) is a direct target of miR-568. PMID: 24355664
  26. These findings support a novel role for the XO-NFAT5 axis in macrophage activation and TLR-induced arthritis. PMID: 25044064
  27. Biomechanical stretch has been found to be sufficient to activate NFAT5 in both native and cultured VSMCs (vascular smooth muscle cells), where it regulates the expression of tenascin-C. PMID: 24614757
  28. NFAT5 regulation of intestinal cell differentiation may involve the inhibition of Wnt/beta-catenin signaling. PMID: 23764852
  29. Nfat5 may play a role in regulating chondrogenic differentiation of cells under both normal and increased osmolarities, potentially influencing early Sox9 expression. PMID: 23219947
  30. Specific DNA binding of NFAT5 contributes to its nuclear localization, through mechanisms that are currently unknown but independent of previously described ones. PMID: 22992674
  31. Non-invasive imaging of nuclear factor of activated T-cell 5 (NFAT5) activation has been successfully performed following middle cerebral artery occlusion (MCAO) in NFAT5-luciferase-expressing mice. PMID: 21749466
  32. NFAT5 is induced by hypoxia and could potentially act as a protective factor against ischemic damage. PMID: 22768306
  33. NFAT5 contributes to osmolality-induced MCP-1 (Monocyte Chemoattractant Protein-1) expression in mesothelial cells. PMID: 22619484
  34. The nuclear transport of NFAT5a involves reversible palmitoylation. PMID: 22071693
  35. The innate immune response to Mycobacterium tuberculosis (MTb) infection induces NFAT5 gene and protein expression. NFAT5 plays a crucial role in MTb regulation of HIV-1 replication through a direct interaction with the viral promoter. PMID: 22496647
  36. Research suggests that NS5A (Nonstructural Protein 5A) modulates Hsp72 (Heat Shock Protein 72) via NFAT5 and reactive oxygen species activation for Hepatitis C virus propagation. PMID: 22497815
  37. TonEBP plays a crucial role in the epithelial cells of the renal proximal tubule upon hypertonic stress by enhancing AAD (Amino Acid Decarboxylase) expression, which promotes dopamine secretion to negatively regulate Na+/K+-ATPase activity. PMID: 21982764
  38. After exposure of HBE16 cells to hypertonic media, the levels of OREBP (Osmolality Responsive Element Binding Protein), HSP70-2, and MUC5AC in the supernatant significantly increased. PMID: 21418859
  39. NFAT5 has been identified as a novel regulator of vascular smooth muscle cell phenotypic modulation. PMID: 21757659
  40. NF-AT5 regulates synovial proliferation and angiogenesis in chronic arthritis. PMID: 21717420
  41. Hyperosmotic stress induces S100A4 expression through NFAT5, with Src and chromatin remodeling playing a role in this process. PMID: 21289293
  42. High NaCl-induced increase in the overall abundance of TonEBP/OREBP, by itself, eventually raises its effective level in the nucleus. However, its rapid CDK5-dependent nuclear localization accelerates this process. PMID: 21209322
  43. These findings reveal a novel role for TonEBP and Akt in NF-kappaB activation upon the onset of hypertonic challenge. PMID: 20685965
  44. NFAT5-null mice exhibit constitutive, pronounced hypernatremia and suffer severe immunodeficiency characterized by T cell lymphopenia, altered CD8 naive/memory homeostasis, and an inability to reject allogeneic tumors. PMID: 21037089
  45. c-Abl is the kinase responsible for high NaCl-induced phosphorylation of TonEBP/OREBP-Y143. PMID: 20585028
  46. TonEBP/OREBP is extensively regulated by phosphatases, including SHP-1, whose inhibition by high NaCl increases phosphorylation of TonEBP/OREBP at Y143, contributing to the nuclear localization and activation of TonEBP/OREBP. PMID: 20351292
  47. The loss of nucleosome(s) was initiated by an OREBP-independent mechanism, but was significantly potentiated in the presence of OREBP. PMID: 20041176
  48. TonEBP/OREBP becomes phosphorylated at Y143, resulting in binding of PLC-gamma1 to that site, which contributes to TonEBP/OREBP transcriptional activity. PMID: 20080774
  49. NFAT5 exclusion from mitotic chromatin resets its nucleo-cytoplasmic distribution in interphase. PMID: 19750013
  50. NFAT5 is present in the placenta at both the RNA and protein levels. PMID: 19886771

Show More

Hide All

Database Links

HGNC: 7774

OMIM: 604708

KEGG: hsa:10725

STRING: 9606.ENSP00000396538

UniGene: Hs.371987

Subcellular Location
Nucleus. Cytoplasm.
Tissue Specificity
Widely expressed, with highest levels in skeletal muscle, brain, heart and peripheral blood leukocytes.

Q&A

What is the functional significance of NFAT5 Ser155 phosphorylation in cellular responses?

Phosphorylation of NFAT5 at Serine 155 represents a key regulatory modification that influences its transcriptional activity. In research contexts, this phosphorylation event is associated with:

  • Enhanced NFAT5-mediated gene activation during hypertonic stress

  • Modulation of nuclear localization and DNA binding capability

  • Regulation of NFAT5's role in amplifying TLR-induced antipathogen transcription responses

NFAT5 plays a pivotal role in facilitating chromatin accessibility, particularly at promoter regions of multiple TLR4-responsive genes. It induces H3K27me3 demethylation, which serves as an early mechanism that facilitates p65/NF-κB recruitment to promoters of various TLR4-induced genes .

How should researchers validate the specificity of Phospho-NFAT5 (Ser155) antibodies?

Proper validation of phospho-specific antibodies is critical for experimental reliability. For Phospho-NFAT5 (Ser155) antibodies, the following validation protocol is recommended:

  • Phosphatase treatment control: Treat cell lysates with lambda phosphatase to remove phosphorylation and confirm loss of signal

  • Stimulation-dependent detection: Compare unstimulated versus hypertonic stress-stimulated cells (300-500 mOsm)

  • Peptide competition assay: Pre-incubate antibody with phosphorylated and non-phosphorylated peptides

  • Knockout/knockdown control: Include NFAT5-deficient cells as negative controls

The antibody should specifically detect NFAT5 only when phosphorylated at Ser155, showing decreased signal in phosphatase-treated samples and NFAT5-deficient cells .

What are the optimal experimental conditions for detecting NFAT5 Ser155 phosphorylation in macrophages?

When studying NFAT5 phosphorylation in macrophage responses, researchers should consider these methodological approaches:

  • Stimulation parameters:

    • Low-dose TLR4 stimulation: 0.05-0.1 ng/ml LPS (critical for observing NFAT5-dependent effects)

    • Hypertonic conditions: NaCl or sorbitol to increase osmolarity by 50-100 mOsm

    • Timing: Initial phosphorylation typically occurs within 30-60 minutes

  • Cell preparation:

    • Primary macrophages can be isolated using anti-CD11b antibodies and magnetic beads

    • Peritoneal macrophages obtained 3 hours after LPS injection (0.05 μg/kg) provide physiologically relevant samples

  • Sample processing:

    • Rapid cell lysis in buffers containing phosphatase inhibitors

    • Processing at 4°C to prevent dephosphorylation

    • Recommended dilution for Western blot: 1:500-1:1000

What experimental evidence demonstrates the relationship between NFAT5 phosphorylation and chromatin remodeling?

Advanced research has revealed NFAT5's role in chromatin accessibility, with Ser155 phosphorylation potentially mediating these effects:

  • Transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) analysis demonstrates that NFAT5:

    • Facilitates chromatin accessibility primarily at promoter regions of multiple TLR4-responsive genes

    • Functions most critically under conditions of mild TLR stimulation

  • Histone modification analysis shows NFAT5-dependent mechanisms:

    • H3K27me3 demethylation as an early NFAT5-dependent process

    • This demethylation facilitates p65/NF-κB recruitment to promoters

    • Inhibition of H3K27me3 demethylases impairs p65/NF-κB recruitment to levels similar to NFAT5-deficient cells

The mechanistic relationship is evident in experiments showing that NFAT5 is required for effective recruitment of central effectors p65/NF-κB and c-Fos to specific proinflammatory target genes including Nos2, Il6, and Tnf in primary macrophages responding to low doses of LPS .

How does NFAT5 function in response to different intensities of TLR stimulation?

NFAT5's role varies depending on stimulation intensity, which is important for experimental design:

TLR Stimulation LevelNFAT5 FunctionObservable EffectsExperimental Condition
Low dose LPS (0.05-0.1 ng/ml)Critical for gene expressionMarked impairment in expression of iNOS, IL-6, TNF-α in NFAT5-deficient cellsEssential for p65/NF-κB recruitment
High dose LPS (>1 ng/ml)Less pronounced roleMinor defects in NFAT5-deficient cellsNFAT5 not required for p65/NF-κB recruitment

This dose-dependent function allows NFAT5 to optimize the expression of genes with different transcription requirements. NFAT5 is readily recruited to the promoters of secondary response genes (Nos2, Il6, Ptgs2) in a TLR-dependent manner but is constitutively bound to promoters of primary response target genes (Tnf, Il1a, Ccl2, Traf1) in steady-state macrophages .

What is the proper methodology for using Phospho-NFAT5 (Ser155) antibodies in Western blotting?

For optimal Western blot results with Phospho-NFAT5 (Ser155) antibodies:

  • Sample preparation:

    • Lyse cells in buffer containing phosphatase inhibitors (Na3VO4, NaF, β-glycerophosphate)

    • Maintain cold conditions throughout processing

    • Use fresh samples when possible or store at -80°C with protease/phosphatase inhibitors

  • Electrophoresis conditions:

    • Use low percentage gels (6-8%) due to NFAT5's high molecular weight (~210 kDa)

    • Include positive controls (cells treated with hypertonic conditions)

  • Antibody application:

    • Recommended dilution: 1:500-1:2000 for Western blotting

    • Overnight incubation at 4°C for primary antibody

    • Block with 5% BSA (not milk) to prevent interference with phospho-epitopes

  • Signal detection:

    • Enhanced chemiluminescence with extended exposure times may be necessary

    • Use high-sensitivity detection systems for low abundance phosphorylated protein

How can researchers distinguish between NFAT5 phosphorylation at Ser155 versus other phosphorylation sites?

Multiple phosphorylation sites exist on NFAT5, requiring careful experimental design:

  • Comparative analysis:

    • Use antibodies specific to different phosphorylation sites (e.g., Ser155 vs Ser145)

    • Compare phosphorylation kinetics under various stimulation conditions

    • Analyze using phospho-site mutants (S155A) to confirm specificity

  • Mass spectrometry approach:

    • Immunoprecipitate NFAT5 and analyze by phospho-peptide mapping

    • Compare phosphorylation profiles under different conditions

    • Quantify relative abundance of phosphorylation at different sites

  • Functional correlation:

    • Compare biological outcomes of mutations at different phosphorylation sites

    • Assess transcriptional activity using reporter assays with phospho-mimetic mutants

Studies have shown that phosphorylation at Ser155 has distinct functional consequences compared to other sites, making site-specific antibodies essential for mechanistic studies.

What are the considerations when using Phospho-NFAT5 (Ser155) antibodies for studying pathogen responses?

When investigating NFAT5's role in antipathogen responses:

  • Experimental timing:

    • Early time points (1-3 hours) for phosphorylation events

    • Later time points (6-24 hours) for gene expression analysis

  • Pathogen selection:

    • TLR4 agonists like LPS are well-characterized for NFAT5 activation

    • NFAT5's role in different TLR pathways (TLR2, TLR3, etc.) requires specific optimization

    • Leishmania infection models have shown NFAT5-dependent control

  • Readout systems:

    • Measure target gene expression (iNOS, IL-6, TNF-α, CCL2)

    • Assess functional outcomes (NO production, bacterial killing)

    • Monitor chromatin accessibility and histone modifications

  • Controls:

    • Include NFAT5-deficient macrophages (LysM-Cre or Csf1r-Cre crossed with NFAT5-floxed mice)

    • Compare low vs. high pathogen burden conditions

How does NFAT5 phosphorylation contribute to biomolecular condensate formation?

Recent advanced research has revealed that NFAT5 forms dynamic, reversible biomolecular condensates in response to increasing ionic strength:

  • Condensate formation mechanism:

    • NFAT5 directly senses solution ionic strength using its C-terminal intrinsically disordered region

    • This self-associative property is conserved from insects to mammals

    • Phosphorylation status, including at Ser155, may regulate condensation properties

  • Functional significance:

    • Condensate formation allows NFAT5 to accumulate in the nucleus

    • This accumulation activates genes that restore cellular ion content

    • Both reduced condensation and excessive aggregation impair NFAT5 activity

  • Experimental approaches to study condensates:

    • Fluorescence recovery after photobleaching (FRAP) to assess dynamics

    • Phase separation assays with purified components

    • Live cell imaging with fluorescently tagged NFAT5

    • Mutation analysis to identify regions critical for condensation

Research has demonstrated that human NFAT5 alone is sufficient to reconstitute a mammalian transcriptional response to ionic or hypertonic stress in yeast, indicating its autonomous sensing capability .

What methodological approaches can detect the interaction between phosphorylated NFAT5 and chromatin?

To investigate how phosphorylated NFAT5 interacts with chromatin:

  • Chromatin immunoprecipitation (ChIP):

    • Use Phospho-NFAT5 (Ser155) antibodies for direct ChIP

    • Sequence analysis of bound regions (ChIP-seq)

    • Focus on promoters of known target genes (Nos2, Il6, Tnf, Akr1b3, Slc5a3, Slc6a12)

  • Transposase-accessible chromatin analysis:

    • ATAC-seq to map regions where NFAT5 induces accessibility changes

    • Compare wild-type vs. NFAT5-deficient cells

    • Analyze under various stimulation conditions

  • Histone modification mapping:

    • ChIP-seq for histone marks (H3K27me3, H3K4me3, etc.)

    • Correlation with NFAT5 binding and phosphorylation status

    • Inhibitor studies of chromatin-modifying enzymes

Research has shown that NFAT5 facilitates chromatin accessibility specifically at promoter regions and enhances H3K27me3 demethylation, which is critical for subsequent recruitment of transcription factors like p65/NF-κB .

How should researchers interpret discrepancies in NFAT5 phosphorylation results across different experimental models?

When facing conflicting results across models:

  • Source variations:

    • Cell type differences: Primary macrophages vs. cell lines vs. in vivo models

    • Species differences: Human vs. mouse (despite high conservation)

    • Genetic background effects: Pure vs. mixed background mice

  • Technical considerations:

    • Antibody specificity: Different commercial antibodies may have varying sensitivities

    • Phosphorylation stability: Rapid dephosphorylation during sample processing

    • Detection methods: Western blot vs. flow cytometry vs. immunofluorescence

  • Stimulus differences:

    • Nature of stimulus: Ionic vs. non-ionic osmolytes

    • Intensity of stimulus: Low vs. high TLR activation

    • Duration of stimulus: Acute vs. chronic exposure

  • Resolution approaches:

    • Use multiple antibodies and detection methods

    • Include appropriate positive and negative controls

    • Validate with genetic approaches (phospho-mimetic or phospho-dead mutants)

What is known about the role of NFAT5 Ser155 phosphorylation in disease contexts?

Emerging research connects NFAT5 phosphorylation to various pathological conditions:

  • Immune dysregulation:

    • NFAT5 haploinsufficiency has been reported in two patients with Epstein-Barr virus susceptibility

    • One case involved chronic-active infection of the liver and bowel

    • Another case resulted in fatal hemophagocytic lymphohistiocytosis

  • Kidney disease:

    • NFAT5 is critical in the renal medulla where high interstitial osmolarity allows water reabsorption

    • Emerging evidence connects NFAT5 dysfunction to chronic kidney disease of unknown origin

    • This may result from failing adaptive mechanisms against extreme or prolonged hypertonic stress

  • Climate-related diseases:

    • Rising temperatures and scarcity of potable water contribute to conditions affecting tissues vulnerable to hypertonic stress

    • NFAT5's phosphorylation status, including at Ser155, may influence adaptive responses

    • This has implications for emerging public health challenges in changing climate conditions

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.